CNS & Addictive Disorders

Addictive disorders are caused by multiple factors, including genetic vulnerability, environmental stressors, social pressures, individual personality characteristics and psychiatric problems. From a neurological standpoint, addictive disorders arise when a substance changes the way the user’s brain feels pleasure. Addictive substances alter the brain’s ability to send and receive chemicals called neurotransmitters, which cause pleasure. The addictive substances can prevent nerves in the brain called neurons from receiving these pleasure chemicals, meaning the drug user relies on the drug, rather than his or her natural brain chemicals, for feelings of pleasure.

Most of the knowledge available regarding substance abuse and use comes from studying adult populations. A lack of research studying young adult substance abuse and use leaves questions concerning how it differs from substance abuse in other age groups unanswered.

Some adolescents are more at risk of developing addictive disorders, including adolescents with one or more of the following conditions present: 1) Children of substance abusers. 2) Adolescents who are victims of physical, sexual or psychological abuse. 3) Adolescents with mental health problems, especially depressed and suicidal teens. 4) Physically disabled adolescents.

    Related Conference of CNS & Addictive Disorders

    Aug 02-04, 2017

    International Meeting on CNS

    Melbourne, Australia
    August 29-31, 2017

    15th European Neurology Congress

    London, UK
    August 29-31, 2017

    6th World Congress on Addiction Disorder & Addiction Therapy

    Prague, Czech Republic
    August 31-September 01, 2017

    3rdInternational Conference on Epilepsy and Treatment

    Brussels, Belgium
    September 07-08, 2017

    Global Experts Meeting on Brain Disorders

    Macau, Hong Kong
    November 16-17, 2017

    Global Experts Meeting on Neurological Disorders and Stroke

    Melbourne, Australia
    Oct 12-13, 2017

    Internatinal Meeting on Addiction Congress

    Osaka, Japan
    Oct 12-13, 2017

    Global Meeting on Dual Diagnosis and Addiction

    Auckland, Newzeland
    October 16-17, 2017

    17th Global Neuroscience Conference

    Osaka, Japan
    Nov 13-14, 2017

    Gobal Experts Meeting on Neuroscience and Neurochemistry

    Melbourne, Australia
    February 22-23, 2018

    11th International Conference on Vascular Dementia

    Paris, France
    July 12-13, 2018

    EuroSciCon Conference on Neurology

    Paris, France

    CNS & Addictive Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in